Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

648 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Generation of adult human T-cell progenitors for immunotherapeutic applications.
Simons L, Ma K, de Chappedelaine C, Moiranghtem RD, Elkaim E, Olivré J, Susini S, Appourchaux K, Reimann C, Sadek H, Pellé O, Cagnard N, Magrin E, Lagresle-Peyrou C, Taghon T, Rausell A, Cavazzana M, André-Schmutz I. Simons L, et al. J Allergy Clin Immunol. 2018 Apr;141(4):1491-1494.e4. doi: 10.1016/j.jaci.2017.10.034. Epub 2017 Dec 5. J Allergy Clin Immunol. 2018. PMID: 29208547 Free PMC article. No abstract available.
A DL-4- and TNFα-based culture system to generate high numbers of nonmodified or genetically modified immunotherapeutic human T-lymphoid progenitors.
Moirangthem RD, Ma K, Lizot S, Cordesse A, Olivré J, de Chappedelaine C, Joshi A, Cieslak A, Tchen J, Cagnard N, Asnafi V, Rausell A, Simons L, Zuber J, Taghon T, Staal FJT, Pflumio F, Six E, Cavazzana M, Lagresle-Peyrou C, Soheili T, André I. Moirangthem RD, et al. Among authors: simons l. Cell Mol Immunol. 2021 Jul;18(7):1662-1676. doi: 10.1038/s41423-021-00706-8. Epub 2021 Jun 11. Cell Mol Immunol. 2021. PMID: 34117371 Free PMC article.
Ex vivo generated human T-lymphoid progenitors as a tool to accelerate immune reconstitution after partially HLA compatible hematopoietic stem cell transplantation or after gene therapy.
André I, Simons L, Ma K, Moirangthem RD, Diana JS, Magrin E, Couzin C, Magnani A, Cavazzana M. André I, et al. Among authors: simons l. Bone Marrow Transplant. 2019 Aug;54(Suppl 2):749-755. doi: 10.1038/s41409-019-0599-9. Bone Marrow Transplant. 2019. PMID: 31431705 Review.
Correction to: Ex vivo generated human T-lymphoid progenitors as a tool to accelerate immune reconstitution after partially HLA compatible hematopoietic stem cell transplantation or after gene therapy.
André I, Simons L, Ma K, Moirangthem RD, Diana JS, Magrin E, Couzin C, Magnani A, Lagresle-Peyrou C, Cavazzana M. André I, et al. Among authors: simons l. Bone Marrow Transplant. 2022 May;57(5):851. doi: 10.1038/s41409-022-01629-2. Bone Marrow Transplant. 2022. PMID: 35297407 No abstract available.
Humoral Responses and Chronic GVHD Exacerbation after COVID-19 Vaccination Post Allogeneic Stem Cell Transplantation.
Pabst C, Benning L, Liebers N, Janssen M, Caille L, Speer C, He L, Schubert ML, Simons L, Hegenbart U, Schönland S, Radujkovic A, Schmitt M, Schnitzler P, Müller-Tidow C, Dietrich S, Dreger P, Luft T. Pabst C, et al. Among authors: simons l. Vaccines (Basel). 2022 Feb 18;10(2):330. doi: 10.3390/vaccines10020330. Vaccines (Basel). 2022. PMID: 35214787 Free PMC article.
Release of P-TEFb from the Super Elongation Complex promotes HIV-1 latency reversal.
Cisneros WJ, Soliman SHA, Walter M, Simons LM, Cornish D, De Fabritiis S, Halle AW, Kim EY, Wolinsky SM, Lorenzo-Redondo R, Shilatifard A, Hultquist JF. Cisneros WJ, et al. Among authors: simons lm. PLoS Pathog. 2024 Sep 11;20(9):e1012083. doi: 10.1371/journal.ppat.1012083. eCollection 2024 Sep. PLoS Pathog. 2024. PMID: 39259751 Free PMC article.
648 results